Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1982 2
1983 1
1984 3
1985 7
1986 16
1987 14
1988 10
1989 8
1990 11
1991 14
1992 15
1993 16
1994 21
1995 23
1996 37
1997 47
1998 39
1999 47
2000 45
2001 53
2002 51
2003 109
2004 106
2005 107
2006 150
2007 202
2008 212
2009 252
2010 268
2011 261
2012 345
2013 412
2014 590
2015 646
2016 665
2017 712
2018 798
2019 914
2020 1110
2021 1236
2022 1343
2023 1292
2024 1516
2025 1819
2026 896

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,670 results

Results by year

Filters applied: . Clear all
Page 1
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.
Duan JC, Zhong J, Sun BY, Zhao WH, Wu L, Fei KL, Chu Q, Guo QS, Song QB, Yu Y, Zhu DX, Liu XY, Zhao J, Zhan ZX, Li S, Nie L, Lin J, Peng XD, Zhong DS, Zhou J, Li LH, Chen YF, Hu C, Mok T, Wang ZJ, Wang J. Duan JC, et al. Among authors: sun by. CA Cancer J Clin. 2026 Mar-Apr;76(2):e70071. doi: 10.3322/caac.70071. CA Cancer J Clin. 2026. PMID: 41818162 Free PMC article. Clinical Trial.
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.
Hunter NB, Parsons HA, Cope L, Canzoniero JV, Navarro FCP, El-Refai S, Anampa JD, Sparano JA, Rimawi M, Storniolo AM, Mainor C, Nanda R, DeMichele A, Gupta GP, Stringer-Reasor EJ, Lynce F, Cobain EF, Puhalla S, Jankowitz R, Rexer B, Mayer I, Hwang ES, Blackwell K, El Ayass W, Lee Y, Tweed C, Wilkinson M, Pennisi A, Sun B, Wright P, Gralow JR, Chen R, Boyle SM, Stearns V, Wolff AC, Park BH. Hunter NB, et al. Among authors: sun b. J Clin Oncol. 2026 May 10;44(14):1283-1295. doi: 10.1200/JCO-25-02934. Epub 2026 Mar 10. J Clin Oncol. 2026. PMID: 41805422
Tuning the sensitivity of mechanosensory receptors through histidine scanning.
Wang Y, Wang Y, Yuan W, Fan M, Wang X, Wang A, Bao Y, Zhang Y, Tan JC, Wang J, Liu J, Huang T, Han Z, Pei B, Chen L, Ren Z, Wang X, Hu L, Wu S, Pang M, Wang S, Yang Z, Li J, Huang D, Shao S, Yuan H, Wu L, Feng Y, Zhou P, Li G, Sun B, Xu C, Gascoigne NRJ, Zhao X. Wang Y, et al. Among authors: sun b. Cell. 2026 Mar 19;189(6):1680-1700.e48. doi: 10.1016/j.cell.2025.12.050. Epub 2026 Feb 18. Cell. 2026. PMID: 41713420
Letter: Abdominal Wall Aspergillosis.
Sun B, Deng J, Kuang R, Zhou J. Sun B, et al. Surg Infect (Larchmt). 2026 Feb 12:10962964261425161. doi: 10.1177/10962964261425161. Online ahead of print. Surg Infect (Larchmt). 2026. PMID: 41680095 No abstract available.
Prophylactic tranexamic acid for the prevention of postpartum haemorrhage in women with placenta praevia: multicentre, double blind, randomised, placebo controlled, phase 3 trial.
Zhang L, Bi S, Chen L, Du L, He F, Qiao Y, Li Z, Zeng W, Zhao X, Chen X, Li X, Ding G, Zhou W, Sun B, Guo Q, Guo X, Jin F, Wang X, Zhu Q, Sun Q, Jiang S, Wang X, Cai F, Jiang Y, Gao J, Wang Z, Wang Z, Zhang L, Liu JM, Huang L, Yu L, Chen J, Zhang S, Poon LC, Li HT, Chen D; study’s collaborator group. Zhang L, et al. Among authors: sun b. BMJ. 2026 May 13;393:e089636. doi: 10.1136/bmj-2026-089636. BMJ. 2026. PMID: 42128454 Free PMC article. Clinical Trial.
Hyocholic acids shape neonatal immune tolerance and microbiota assembly.
Zheng X, Wang J, Sun Y, Zhang H, Tang Y, Kuang J, Jiao F, Zhou C, Xia M, Ren J, Cai Y, Yao C, Zhao A, Qu C, Liu L, Yang Y, Guan Q, Jiang R, Ren Z, Chen T, Li M, Xia X, Xia L, Zhao M, Li Y, Ding K, Zhou Z, Shi Y, Wan X, Sun B, Xie G, Gao F, Zhou J, Hu C, He Y, Jia W, Xie RH, Jia W. Zheng X, et al. Among authors: sun b. Cell Metab. 2026 May 20:S1550-4131(26)00154-3. doi: 10.1016/j.cmet.2026.04.016. Online ahead of print. Cell Metab. 2026. PMID: 42167251 Free article.
Reinforced biotubes as readily available and regenerative vascular grafts.
Cheng Q, Zhi D, Midgley AC, Wan Y, Li Y, Zhang R, Ping X, Sun B, Shi Y, Zheng J, Zhang S, Liu B, Wei T, Zhang Q, Ma T, Rafique M, Fu Q, Liang X, Walpoth BH, Wang P, Zhao Y, Wang T, Zhao Q, Ye X, Zhu M, Kong D, Wang K. Cheng Q, et al. Among authors: sun b. Nat Commun. 2026 Mar 23;17(1):4300. doi: 10.1038/s41467-026-70799-0. Nat Commun. 2026. PMID: 41866390 Free PMC article.
RNA modifications and cancer ferroptosis.
Xie Y, Sun B, Chen W, Jia X, Fan Y, Xu Z, Liu H, Gu X, Ma F. Xie Y, et al. Among authors: sun b. Cancer Cell Int. 2026 Mar 28;26(1):191. doi: 10.1186/s12935-026-04279-2. Cancer Cell Int. 2026. PMID: 41904565 Free PMC article. Review.
The CGCG response assessment criteria for spinal cord gliomas.
Wang Y, Jia W, Chai R, Xia W, Wang L, Qiu X, Liu Y, Zhang W, Kang C, Wang Y, Liu Y, An S, Sun T, Zhang Y, Liu Y, Pang B, Li N, Zhang Z, Yan H, Zhang Y, Chang Y, Fan W, Wang L, Sun B, Jiang T; Chinese Glioma Cooperative Group (CGCG). Wang Y, et al. Among authors: sun b. Cancer Lett. 2026 May 28;646:218415. doi: 10.1016/j.canlet.2026.218415. Epub 2026 Mar 6. Cancer Lett. 2026. PMID: 41796847 Review.
14,670 results
You have reached the last available page of results. Please see the User Guide for more information.